SCHEDULE OF WARRANT ACTIVITY (Details) - Warrant [Member] |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of Warrants, Outstanding | shares | 3,882,755 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 0.08 |
| Number of Warrants, Issued | shares | |
| Weighted Average Exercise Price, Issued | $ / shares | |
| Number of Warrants, Expired | shares | (283) |
| Weighted Average Exercise Price, Expired | $ / shares | |
| Number of Warrants, Exercised | shares | (90,962) |
| Weighted Average Exercise Price, Exercised | $ / shares | $ 0.08 |
| Number of Warrants, Outstanding | shares | 3,791,510 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 0.08 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options exercised in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options expired in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|